[1] Attarian S, Fatehi F, Rajabally Y A, et al. Hereditary neuropathy with liability to pressure palsies [J]. J Neurol, 2020, 267(8): 2198-2206.
[2] Paassen B W, Kooi A J, Spaendonck K Y, et al. PMP22 related neuropathies: charcot-marie-tooth disease type 1A and hereditary neuropathy with liability to pressure palsies [J]. Orphanet J Rare Dis, 2014, 9: 38.
[3] 曹婉芊, 黄顺祥, 赵华栋, 等. 遗传性压力易感性周围神经病24个家系的临床和分子遗传学特征及文献回顾[J]. 中南大学学报(医学版), 2023, 48(10): 1572-1582.
[4] Guo J, Wang L, Zhang Y, et al. Abnormal junctions and permeability of myelin in PMP22-deficient nerves [J]. Ann Neurol, 2014, 75(2): 255-265.
[5] Robert V F, Jousserand G, Bouhour F, et al. Hereditary neuropathy with liability to pressure palsy in patients under 30 years old: neurophysiological data and proposed electrodiagnostic criteria [J]. Muscle Nerve, 2018, 57(2): 217-221.
[6] 蓝梅平, 周瑞玲. 遗传性压力易感性周围神经病患者的临床与神经电生理分析[J]. 癫痫与神经电生理学杂志, 2024, 33(3): 181-185.
[7] Blomqvist M, Zetterberg H, Blennow K, et al. Sulfatide in health and disease. the evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration [J]. Mol Cell Neurosci,2021, 116:103670.
[8] Moriguchi K, Nakamura Y, Park A M, et al. Anti-glycolipid antibody examination in five EAE models and theiler’s virus model of multiple sclerosis: detection of anti-GM1, GM3, GM4, and sulfatide antibodies in relapsing-remitting EAE [J]. Int J Mol Sci, 2023, 24(16): 12937.
[9] Sun R, Meng Y, Li L, et al. A rare presentation of acute-onset chronic inflammatory demyelinating polyneuropathy with the detection of anti-GM3 and anti-sulfatides antibodies: a case report [J]. Front Immunol, 2024, 15: 1409637.
[10] Kleiser B, Giesche N, Kowarik M C, et al. Anti-sulfatide antibodies in neurological disorders: should we test? [J]. J Neurol, 2024, 271(12):7613-7618.
[11] 孙 佳, 张巧莲, 朱 洁, 等. 以共济失调为主要表现的吉兰-巴雷综合征7例[J]. 武警医学, 2023, 34(6): 519-521.
[12] Chen L, Zhang H, Li C, et al. Literature review of clinical analysis of hereditary neuropathy with liability to pressure palsies [J]. J Neurol,2024, 272(1):41.
[13] Moss K R, Bopp T S, Johnson A E, et al. New evidence for secondary axonal degeneration in demyelinating neuropathies [J]. Neurosci Lett,2021, 744:135595.